Form 8-K Alkermes plc. For: Feb 14

Go back to Form 8-K Alkermes plc. For: Feb 14

Alkermes (ALKS) PT Raised to $70 at Credit Suisse; 'While 4230 Excites the Street, We Look for Progress With Vivitrol and 5461'

February 16, 2018 8:30 AM EST

Credit Suisse raised its price target on Alkermes (NASDAQ: ALKS) to $70.00 (from $66.00) while maintaining a Outperform rating.

... More